NBC News

EDAP Features New Ablatherm(R) HIFU Data Supporting Superior Efficacy for Treatment of Local Prostate Cancer at American Urological Association Annual Meeting

LYON, France, May 12, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced Ablatherm ® High Intensity Focused Ultrasound (HIFU) will be ...
Finanznachrichten

Largest Long-Term Study Confirms EDAP's Ablatherm HIFU is Effective, Highly Reproducible Primary Treatment for Localized Prostate Cancer

LYON, France, May 17, 2011 /PRNewswire/ -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, announced today that new 10 year data from an international registry-based ...
Business Insider

EDAP's Ablatherm® Robotic HIFU: Clinical Results Support High-Intensity Focused Ultrasound (HIFU) for Prostate Tissue Ablation after Unsuccessful Radiotherapy

LYON, France, March 22, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the publication of a peer-reviewed article that analyzed Ablatherm Robotic HIFU ...
Finanznachrichten

EDAP Announces Second Sale to 'La Mutualite Francaise'; French Public Clinics Expand Ablatherm HIFU Commitment

LYON, France, Jan. 10 /PRNewswire-FirstCall/ -- EDAP TMS S.A. , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, announces ...
FierceBiotech

Ablatherm ultrasound prostate cancer treatment rebuffed by FDA panel

The FDA's Gastroenterology & Urology Devices panel came down firmly against EDAP's Ablatherm system for treating low-risk, localized prostate cancer. The panel voted 9-0 on the device's effectiveness, ...
NBC News

Published 15-Year Clinical Review Supports EDAP's Ablatherm(R) HIFU as Viable Primary Treatment for Local Prostate Cancer at Any Stage

LYON, France, May 9, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced a published 15-year clinical review of Ablatherm ® HIFU data supports ...
BioWorld

FDA advisory committee: EDAP's Ablatherm PMA falters at adcomm over poor efficacy data

GAITHERSBURG, Maryland — The Ablatherm PMA by EDAP (Lyon, France) faltered at a July 30 FDA advisory committee despite that the device has been available in Europe for more than a decade, raising ...
Becker's ASC

Gramercy Surgery Center hosts 1st Ablatherm Robotic HIFU prostate ablation: 5 key notes

The first prostate ablation treatment with the Ablatherm Robotic HIFU was performed at the Gramercy Surgery Center in New York. 1. Ivan Grunberger, MD, chief of urology at New York Methodist Hospital ...
Business Insider

EDAP Partners with Leading US HIFU provider, Vituro Health Adds Ablatherm Robotic HIFU

Dr. S. Scionti, Medical Director of Vituro and most experienced HIFU urologist in the U.S. to start treating with Ablatherm in September LYON, France, August 31, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the ...
London South East

PRESS RELEASE: EDAP Announces New Ablatherm HIFU Site at Cleveland Clinic Canada in Toronto, Canada

EDAP Announces New Ablatherm HIFU Site at Cleveland Clinic Canada in Toronto, Canada Ablatherm HIFU Operated by Exclusive Distributor in Canada, Maple Leaf HIFU LYON, France, June 29, 2010 (GLOBE ...
Nasdaq

EDAP Announces Sale of Robotic Focal One® HIFU Device to University of Miami

LYON, France, January 29, 2020 – EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the University of Miami Sylvester Comprehensive ...